Russell Investments Group’s Abeona Therapeutics ABEO Stock Holding History

Russell Investments Group’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$176K	Buy	28,417 +14,363	+102%	+$78.9K	﹤0.01%	3231
2026 Q1	$63K	Buy	14,054 +959	+7%	+$4.79K	﹤0.01%	3239
2025 Q4	$69K	Buy	13,095 +6,013	+85%	+$30.3K	﹤0.01%	3181
2025 Q3	$37.4K	Buy	+7,082	New	+$44.9K	﹤0.01%	3389
2021 Q3	–	Sell	-37,279	Closed	-$1.45M	–	3023
2021 Q2	$1.45M	Buy	37,279 +28,621	+331%	+$1.17M	﹤0.01%	2123
2021 Q1	$406K	Hold	8,658	–	–	﹤0.01%	2607
2020 Q4	$339K	Buy	8,658 +3,519	+68%	+$120K	﹤0.01%	2576
2020 Q3	$131K	Buy	+5,139	New	+$324K	﹤0.01%	2919

Other funds holding ABEO

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OIA

OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Russell Investments Group's ABEO Position: Q2 2026 in Review

Russell Investments Group increased its Abeona Therapeutics (ABEO) stake by 102% in Q2 2026, buying an estimated $78.9K and bringing the position to 28,417 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #3231.

Russell Investments Group first reported a position in ABEO in Q3 2020 and has held it in 8 quarters since. The position peaked at $1.45M in Q2 2021. 127 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

Russell Investments Group held 28,417 shares of Abeona Therapeutics worth $176K as of Q2 2026.
Russell Investments Group bought 14,363 Abeona Therapeutics shares in Q2 2026, an estimated $78.9K.
Abeona Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3231 holding.
Russell Investments Group first reported a position in Abeona Therapeutics in Q3 2020 and has held it in 8 quarters since.
Russell Investments Group's Abeona Therapeutics position peaked at $1.45M in Q2 2021.
127 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.